The founders of Ginkgo Bioworks are returning the favor to the next generation of biotech startups by making their world-class cell engineering platform available to innovators at two high-profile accelerators. The synbio stack is alive and well.

Louis Pasteur may not recognize the lab of today, much less the lab of tomorrow. Maybe it’s time to look around our own labs today and see where we can clear a little space on the bench for Evonetix’s DNA writer.

Meet Berkeley Lights, a company with the optofluidics-based technology with the unprecedented ability to find and recover rare cells that is disrupting antibody discovery and cell line development by increasing quality and shortening timelines.